CBRE ACQUISITION HOLDINGS-A (CBAH) Stock Fundamental Analysis

NYSE:CBAH

10.75
+0.65 (+6.44%)
At close: Dec 9, 2021
10.94
+0.19 (+1.77%)
After Hours: 12/9/2021, 8:15:12 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CBAH. CBAH was compared to 0 industry peers in the Unkown industry. CBAH may be in some trouble as it scores bad on both profitability and health. CBAH is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year CBAH has reported negative net income.
CBAH Yearly Net Income VS EBIT VS OCF VS FCFCBAH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 -500K -1M -1.5M

1.2 Ratios

Industry RankSector Rank
ROA -0.07%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CBAH Yearly ROA, ROE, ROICCBAH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 -0.02 -0.04 -0.06 -0.08

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for CBAH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CBAH Yearly Profit, Operating, Gross MarginsCBAH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • There is no outstanding debt for CBAH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CBAH Yearly Shares OutstandingCBAH Yearly Shares OutstandingYearly Shares Outstanding 2020 10M 20M 30M 40M
CBAH Yearly Total Debt VS Total AssetsCBAH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 100M 200M 300M 400M

2.2 Solvency

  • An Altman-Z score of 6.83 indicates that CBAH is not in any danger for bankruptcy at the moment.
  • CBAH has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 6.83
ROIC/WACCN/A
WACCN/A
CBAH Yearly LT Debt VS Equity VS FCFCBAH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 100M 200M 300M

2.3 Liquidity

  • CBAH has a Current Ratio of 0.47. This is a bad value and indicates that CBAH is not financially healthy enough and could expect problems in meeting its short term obligations.
  • A Quick Ratio of 0.47 indicates that CBAH may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.47
CBAH Yearly Current Assets VS Current LiabilitesCBAH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 500K 1M 1.5M 2M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, CBAH will show a very strong growth in Earnings Per Share. The EPS will grow by 129.47% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-43.68%
EPS Next 2Y-107.62%
EPS Next 3Y129.31%
EPS Next 5Y129.47%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CBAH Yearly EPS VS EstimatesCBAH Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 0 0.1 0.2 0.3 0.4

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CBAH. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CBAH. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CBAH Price Earnings VS Forward Price EarningsCBAH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600 -800 -1K

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CBAH Per share dataCBAH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • CBAH's earnings are expected to grow with 129.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-107.62%
EPS Next 3Y129.31%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for CBAH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

CBRE ACQUISITION HOLDINGS-A

NYSE:CBAH (12/9/2021, 8:15:12 PM)

After market: 10.94 +0.19 (+1.77%)

10.75

+0.65 (+6.44%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners71.77%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap454.32M
Revenue(TTM)N/A
Net Income(TTM)-300.00K
Analysts100
Price Target14.28 (32.84%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.24
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS8.65
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.07%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score0
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.47
Quick Ratio 0.47
Altman-Z 6.83
F-Score0
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-43.68%
EPS Next 2Y-107.62%
EPS Next 3Y129.31%
EPS Next 5Y129.47%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

CBRE ACQUISITION HOLDINGS-A / CBAH FAQ

What is the ChartMill fundamental rating of CBRE ACQUISITION HOLDINGS-A (CBAH) stock?

ChartMill assigns a fundamental rating of 0 / 10 to CBAH.


What is the valuation status for CBAH stock?

ChartMill assigns a valuation rating of 1 / 10 to CBRE ACQUISITION HOLDINGS-A (CBAH). This can be considered as Overvalued.


Can you provide the profitability details for CBRE ACQUISITION HOLDINGS-A?

CBRE ACQUISITION HOLDINGS-A (CBAH) has a profitability rating of 0 / 10.


How financially healthy is CBRE ACQUISITION HOLDINGS-A?

The financial health rating of CBRE ACQUISITION HOLDINGS-A (CBAH) is 1 / 10.